Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial

Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, Kevin Ng, Xueyan Chen, Jenny Mao, Brianna Woo, Aaron Lin, Andrii Hannochka, Nathan Conrad, Martha Kahugu, Patrick Panlasigui, Michael C. Haffner, Andrew C. Hsieh, Hung‐Ming Lam, Funda Vakar‐Lopez, Todd Yezefski, Michael T. Schweizer, Bruce Montgomery, Evan Y. Yu, Atreya Dash, Sarah P. Psutka, Daniel W. Lin, George R. Schade, John L. Gore, Jonathan L. Wright, Petros Grivas